Table 1 Patient background.

From: Histone deacetylase 6 and programmed death ligand-1 expressions after neoadjuvant chemotherapy are upregulated in patients with ovarian high-grade serous carcinoma

Variables

N

Age

 Median (range)

58.0 (41–79)

 ≤ 60

34

 > 60

23

CA125 (U/mL)

 Median (range)

3517 (73–24,200)

 ≤ 1,000

23

 > 1,000

34

KELIM score

Median (range)

1.2 (0.37–2.1)

 <1

 

 ≥1

 

Treatment

 NAC + IDS

55

 NAC without IDS

2

FIGO stage

 III

43

 IV

14

Residual tumor at IDS

 R0

37

 R1

20

CRS (omentum)

 1 = resistant

9

 2 = intermediate

16

 3 = sensitive

29

 Not available

3

Recurrence

 Yes

50

 No

7

Death

 Yes

25

 No

32

  1. NAC neoadjuvant chemotherapy, IDS interval debulking surgery, CRS chemotherapy response score, CA125 cancer antigen 125, KELIM cancer antigen 125 ELIMination rate constant K, FIGO international federation of gynecology and obstetrics.
Back to article page